Recombinant Technology Driving Next-Gen Avian Influenza Defense 2026 The Strategic Shift to Genetically Engineered Protection
The global fight against rapidly mutating avian pathogens, especially highly pathogenic Avian Influenza (AI), is undergoing a strategic shift towards Recombinant Vector Vaccines. These advanced products use genetic engineering to insert specific genes from a target pathogen (like AI) into a harmless viral vector (like HVT or poxvirus)....
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
